While there may not be new DSCSA regulations going live in 2021, that doesn’t mean manufacturers can take a break from thinking about their DSCSA and serialization strategy this year. The 2023 requirements still loom ahead. In fact, though technical challenges, operational hurdles, and COVID-19 all spurred a delay in the wholesaler saleable returns requirements, the FDA has noted on several occasions that they do not intend to [...]
Veteran team member promoted to CEO; additional leadership promotions announced to renew focus on client service. COLUMBUS, Ohio (January 2021) - Two Labs, an industry-leading pharma services company based in Columbus, Ohio, announced several senior leadership promotions today. This comes on the heels of their Nov. 11 announcement of their acquisition by Envision Pharma Group. Along with Howard Miller – who has been with Two Labs for 14 years, [...]
Envision Pharma Group acquires Two Labs to advance its position as a global strategic partner to pharma and create a unique and unrivaled launch excellence offering Acquisition follows increased investment in Envision from GHO Capital and its partners London, UK, November 12, 2020 Two Labs brings market-leading commercialization, strategic consulting, market access, and market intelligence solutions that span the full product life cycle Move builds on [...]
Over the last year, biosimilars have seen increasing success in the US market. The number of biosimilars approved has accelerated, product sales for biosimilars are increasing, net prices are being driven down (for both brands and biosimilars), and payers are beginning to prefer biosimilars over brands on their formularies. In this white paper, we take a closer look at these trends, providing an in-depth analysis of the US [...]
3PLs aren’t just a logistics solution – they’re an extension of your business, and few things are as important to the success of your launch as selecting the right 3PL partner. In the midst of the pandemic, it’s more important than ever to have the tools you need to effectively vet a 3PL candidate, as introductory meetings and facilities tours are often truncated or entirely virtual. Read more from Jessica [...]
Globalizing Medical Affairs can often pull teams away from focusing on their local needs. Our Medical Affairs solution identifies challenges that impede globalization efforts and recommends tactics for optimizing both local and global operations. A one-size-fits-all approach is not sufficient to meet the needs of local and global Medical Affairs – every organization has unique challenges that must be considered in order to successfully globalize. Read more from Two Labs’ [...]
State licensing is one of the most difficult, unpredictable aspects of launching a new drug. Two Labs insulates your company from costly pitfalls that can easily derail your launch, while ensuring that you’re in the know about how to remain compliant. Read more from Two Labs’ Ryan Fields, VP of PharmaLicense about the boxes you need to check during the state licensing process. Read more on PM360
Two Labs Named as a Top Workplace by Columbus CEO Magazine Powell-based pharma services company listed as fifth best small employer in central Ohio Two Labs has been awarded a Top Workplaces 2020 honor by Columbus CEO. The Top Workplaces program, which is now in its 8th year honors companies who put their employees and their environment first. Any employer – private, public, nonprofit or governmental - [...]
Cell & Gene therapies are too important to have prescriptions impeded by cost. Two Labs develops unique, advanced payer-strategy models that help alleviate payer challenges and increase prescription of C&G treatments. Read more from Two Labs’ Senior Consultant Anne Runyan about how our Cell & Gene payer strategy helps get life-changing therapies to patients who need them: Read more on Pharmaceutical Commerce
COVID-19 is impacting the healthcare system in a way we’ve never seen before, and pharmaceutical manufacturers are facing new challenges at rapid speeds. To help keep you informed, we’re releasing a special Q&A series with our experts to discuss the virus’s impact on each stage of the launch journey. Today, we spoke with Vice President of PharmaLicense Ryan Fields about the effect of COVID-19 on state licensing. [...]